What Are GLP-1 Drugs?
GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications originally developed for Type 2 diabetes. Semaglutide (branded as Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) mimic a natural gut hormone that reduces appetite, slows gastric emptying, and improves insulin sensitivity.
The weight loss results are dramatic. Clinical trials show average weight loss of 15–22% of body weight over 68 weeks with tirzepatide, and 12–16% with semaglutide. These are numbers that no diet or exercise intervention has ever matched in controlled trials.
For cyclists obsessed with watts per kilogram, the appeal is obvious. Lose 10 kg without changing your training, and your W/kg jumps significantly. But the physiology is not that simple.
WADA's Position: Monitoring, Not Banned (Yet)
In September 2025, the World Anti-Doping Agency added semaglutide and tirzepatide to its monitoring program, effective January 1, 2026. This means WADA is now collecting data on the prevalence of these substances in athlete samples, but they are not yet banned.
The monitoring program is the first step toward a potential ban. WADA uses it to gather evidence before making a prohibition decision. Substances typically spend 1–3 years on the monitoring list before being either added to the prohibited list or removed from monitoring.
The timeline matters: if WADA determines that GLP-1 agonists provide a performance advantage (primarily through weight loss improving W/kg), a ban could be in place before the 2028 Los Angeles Olympics. Several anti-doping experts have publicly stated that a ban is more likely than not.
For age-group and amateur cyclists competing in sanctioned events, the message is clear: using GLP-1 drugs for weight loss is currently legal but carries the risk of future retrospective scrutiny and reputational damage. More importantly, the performance case is weaker than it appears.
The W/kg Math: Why Weight Loss Is Not Free Speed
The W/kg equation is deceptively simple: power (watts) divided by body weight (kg). Reduce the denominator and the ratio improves, right?
In theory, yes. In practice, weight loss almost never comes exclusively from fat. And that changes the equation entirely.
The Muscle Loss Problem
Studies on GLP-1 agonist-induced weight loss consistently show that 25–40% of the weight lost is lean mass, not fat. A rider who loses 10 kg on semaglutide can expect to lose 2.5–4 kg of muscle tissue alongside 6–7.5 kg of fat.
Muscle produces power. Losing muscle means losing watts. Let us run the numbers with a concrete example.
| Scenario | Weight | FTP | W/kg | Change |
|---|---|---|---|---|
| Baseline | 82 kg | 260 W | 3.17 | — |
| GLP-1 weight loss (-10 kg) | 72 kg | 238 W | 3.31 | +4.4% |
| Training only (+25 W FTP) | 82 kg | 285 W | 3.48 | +9.8% |
| Training + sensible weight loss (-4 kg) | 78 kg | 285 W | 3.65 | +15.1% |
The GLP-1 shortcut yields a modest 4.4% improvement in W/kg — at the cost of 22 watts of threshold power. Meanwhile, structured training alone produces a 9.8% improvement. Combined with gradual, training-supported weight loss, the improvement is 15.1%.
The drug-assisted weight loss looks less impressive when you realize it comes with reduced absolute power. On flat terrain, where raw watts and aerodynamics matter more than W/kg, the GLP-1 user is actually slower. The improvement only appears on climbs, and even there it is smaller than what structured training delivers.
Key takeaway
GLP-1 weight loss includes 25–40% lean mass, which means lost watts. Structured training produces better W/kg improvements without sacrificing power, recovery capacity, or long-term health. The shortcut is slower than the real work.
Beyond the Numbers: What GLP-1 Drugs Do to Athletes
The side effects of GLP-1 agonists are well-documented in clinical populations, but their impact on training athletes adds specific concerns.
Reduced Recovery Capacity
Muscle loss impairs recovery. With less muscle mass, every training session causes proportionally more damage to the remaining tissue. Athletes on GLP-1 drugs consistently report increased fatigue, longer recovery between sessions, and reduced ability to absorb training volume. You cannot train as hard and you cannot recover as fast.
Gastrointestinal Issues
Nausea, vomiting, and reduced appetite are the most common side effects, affecting 30–50% of users. For athletes, this directly impacts on-bike fueling. If you cannot tolerate 60–90 g of carbohydrate per hour during a long ride because semaglutide is suppressing your appetite and slowing gastric emptying, your performance on rides over 2 hours will suffer regardless of what your W/kg says.
Bone Density Concerns
Rapid weight loss from any cause stresses bone mineral density. Cycling already carries elevated osteoporosis risk (it is a non-weight-bearing sport). Adding rapid pharmacological weight loss on top of a sport that does not stimulate bone formation is a concerning combination, particularly for female cyclists who face additional bone density challenges.
Rebound Weight Gain
The STEP-1 extension trial showed that patients who stopped semaglutide regained two-thirds of the lost weight within one year. GLP-1 drugs do not fix the underlying metabolic or behavioral factors. They suppress appetite as long as you take them. Stop, and the weight returns — but the muscle you lost does not come back automatically.
The Healthy Alternative: Training-Based Body Composition
There is a proven, sustainable, and performance-enhancing path to better body composition. It does not require a prescription, costs nothing, and has zero side effects. It just requires patience.
Rate of Weight Loss
Research on athletes consistently shows that 0.5 kg per week is the maximum safe rate of weight loss during a training block. Faster than that and you start losing muscle, impairing recovery, and compromising immune function. At 0.5 kg/week, a 4 kg weight loss takes 8 weeks — roughly one base phase.
The optimal time for weight loss is during your base training phase, when training intensity is lower and the metabolic demands are more forgiving. Never attempt a calorie deficit during a build or peak phase.
Protect Protein Intake
The single most important nutritional strategy during a weight-loss phase is maintaining protein intake at 1.6–2.2 g per kg of body weight. Protein preserves muscle mass during a calorie deficit and supports the training adaptation that maintains power output.
A 2023 study in the Journal of the International Society of Sports Nutrition found that cyclists who maintained high protein intake during a 6-week calorie deficit lost the same amount of total weight as a lower-protein group but retained 2.3 kg more lean mass. The high-protein group also maintained their FTP while the lower-protein group lost 8 watts.
Periodize Your Nutrition
You do not need to be in a calorie deficit every day. On heavy training days, eat to fuel the work. On rest days and easy days, moderate your intake. This “fuel for the work required” approach allows you to maintain performance on key sessions while creating a weekly calorie deficit from lower-intake days.
Practical example: for a 78 kg rider targeting 0.5 kg/week loss, the weekly deficit is approximately 3,500 kcal. Spread across 3 rest/easy days at −700 kcal and 2 moderate days at −700 kcal, with 2 hard training days at maintenance or slight surplus.
The Danger Zone: RED-S, Bone Density, and Immune Suppression
Whether weight loss comes from GLP-1 drugs or excessive dieting, the risks of going too far are identical and severe.
Relative Energy Deficiency in Sport (RED-S)
RED-S occurs when energy intake chronically falls below what the body needs for basic physiological function plus training. It affects hormonal function, bone health, immune response, cardiovascular health, and mental health. In male cyclists, it manifests as reduced testosterone, chronic fatigue, and recurrent illness. In female cyclists, the first warning sign is often menstrual irregularity or absence.
Bone Density
Cycling is already a risk factor for low bone density because it is non-impact. Add energy restriction (from any cause) and the risk compounds. A 2024 study found that male cyclists with sub-clinical energy deficiency had bone density values 12% below age-matched controls — a level associated with increased fracture risk.
Immune Suppression
Heavy training plus calorie restriction is a well-documented path to immune suppression. Upper respiratory tract infections increase, training consistency drops, and the lost training days often cost more fitness than the weight loss gained. The immune system is not something you can ignore until it forces you off the bike.
Key takeaway
The fastest path to a better W/kg is structured training, not weight loss. When weight loss is appropriate, lose no more than 0.5 kg/week, maintain 1.6–2.2 g/kg protein, do it during your base phase, and never compromise fueling for key sessions. GLP-1 drugs trade long-term performance for short-term scale numbers.
The Ethical Dimension
Even setting aside performance and health, there is an ethical question worth addressing. GLP-1 drugs are in global shortage. Patients with Type 2 diabetes — the population these drugs were designed for — face difficulty accessing their medication because of demand from weight-loss seekers.
Using a scarce medical resource to shave seconds off a Strava segment raises questions that every athlete should consider for themselves. The cycling community has spent decades fighting the culture of pharmaceutical shortcuts. The substance changes, but the principle remains the same.
The Bottom Line for Cyclists
GLP-1 drugs produce impressive weight loss numbers on a scale. But for cyclists, the scale does not tell the whole story. The muscle loss, the impaired recovery, the gastrointestinal side effects, the bone density risk, and the inevitable rebound weight gain make this a poor performance strategy — even before WADA potentially bans it.
The math favors training. A single dedicated season of structured intervals, adequate fueling, and patient periodization will improve your W/kg more than semaglutide, without the side effects, without the cost, and without the ethical questions. The bike rewards the work. There are no shortcuts to sustainable fitness.